Lindenwold Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,819
Closed -$1.09M 115
2025
Q2
$1.09M Buy
13,819
+113
+0.8% +$8.98K 0.57% 50
2025
Q1
$1.23M Sell
13,706
-109
-0.8% -$10.2K 0.69% 45
2024
Q4
$1.37M Sell
13,815
-316
-2% -$32.6K 0.73% 43
2024
Q3
$1.6M Buy
14,131
+54
+0.4% +$6.42K 0.81% 40
2024
Q2
$1.74M Sell
14,077
-96
-0.7% -$12.4K 0.93% 37
2024
Q1
$1.87M Sell
14,173
-205
-1% -$25.3K 1% 37
2023
Q4
$1.57M Sell
14,378
-43
-0.3% -$4.46K 0.89% 39
2023
Q3
$1.48M Sell
14,421
-47
-0.3% -$5.07K 0.92% 36
2023
Q2
$1.67M Sell
14,468
-2,324
-14% -$264K 1.02% 35
2023
Q1
$1.79M Buy
16,792
+254
+2% +$27.4K 1.11% 35
2022
Q4
$1.83M Buy
16,538
+88
+0.5% +$8.99K 1.23% 27
2022
Q3
$1.42M Buy
16,450
+176
+1% +$15.7K 1.05% 35
2022
Q2
$1.48M Buy
16,274
+57
+0.4% +$5.05K 1.06% 36
2022
Q1
$1.33M Sell
16,217
-567
-3% -$44.7K 0.82% 43
2021
Q4
$1.29M Buy
+16,784
New +$1.34M 0.75% 45

Other funds holding MRK

Lindenwold Advisors's MRK Position: Q3 2025 in Review

Lindenwold Advisors sold out of Merck (MRK) in Q3 2025, closing a stake of 13,819 shares — an estimated $1.09M sold.

Lindenwold Advisors first reported a position in MRK in Q4 2021 and held it in 15 quarters. The position peaked at $1.87M in Q1 2024. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Lindenwold Advisors reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Lindenwold Advisors sold 13,819 Merck shares in Q3 2025, an estimated $1.09M.
  • Lindenwold Advisors first reported a position in Merck in Q4 2021 and held it in 15 quarters.
  • Lindenwold Advisors's Merck position peaked at $1.87M in Q1 2024.
  • 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Lindenwold Advisors's 13F filing for Q3 2025, filed 16 Dec 2025.